These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36216752)

  • 1. Antidiabetic treatment and COVID-19 Outcomes: A population-based cohort study in primary health care in Catalonia during the first wave of the pandemic.
    Ouchi D; Vilaplana-Carnerero C; de Dios V; Giner-Soriano M; Morros R
    Prim Care Diabetes; 2022 Dec; 16(6):753-759. PubMed ID: 36216752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world antidiabetic drug use and fracture risk in 12,277 patients with type 2 diabetes mellitus: a nested case-control study.
    Losada E; Soldevila B; Ali MS; Martínez-Laguna D; Nogués X; Puig-Domingo M; Díez-Pérez A; Mauricio D; Prieto-Alhambra D
    Osteoporos Int; 2018 Sep; 29(9):2079-2086. PubMed ID: 29860664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study.
    Pérez-Belmonte LM; Torres-Peña JD; López-Carmona MD; Ayala-Gutiérrez MM; Fuentes-Jiménez F; Jorge Huerta L; Muñoz JA; Rubio-Rivas M; Madrazo M; Garcia MG; Montes BV; Sola JF; Ena J; Ferrer RG; Pérez CM; Ripper CJ; Lecumberri JJN; Acedo IEA; Canteli SP; Cosío SF; Martínez FA; Rodríguez BC; Pérez-Martínez P; Ramos-Rincón JM; Gómez-Huelgas R;
    BMC Med; 2020 Nov; 18(1):359. PubMed ID: 33190637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study.
    Oh TK; Song IA
    Acta Diabetol; 2021 Jun; 58(6):771-778. PubMed ID: 33582839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes.
    Johnson JA; Majumdar SR; Simpson SH; Toth EL
    Diabetes Care; 2002 Dec; 25(12):2244-8. PubMed ID: 12453968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
    Bowker SL; Majumdar SR; Veugelers P; Johnson JA
    Diabetes Care; 2006 Feb; 29(2):254-8. PubMed ID: 16443869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain).
    Giner-Soriano M; Gomez-Lumbreras A; Vedia C; Ouchi D; Morros R
    BMC Prim Care; 2022 Jun; 23(1):147. PubMed ID: 35676639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Association Between Antidiabetic Agents and Clinical Outcomes of COVID-19 Patients With Diabetes: A Bayesian Network Meta-Analysis.
    Chen Y; Lv X; Lin S; Arshad M; Dai M
    Front Endocrinol (Lausanne); 2022; 13():895458. PubMed ID: 35692410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy.
    Ojeda-Fernández L; Foresta A; Macaluso G; Colacioppo P; Tettamanti M; Zambon A; Genovese S; Fortino I; Leoni O; Roncaglioni MC; Baviera M
    Diabetes Obes Metab; 2022 May; 24(5):891-898. PubMed ID: 35014746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular events and mortality among type 2 diabetes mellitus patients newly prescribed first-line blood glucose-lowering drugs monotherapies: A population-based cohort study in the Catalan electronic medical record database, SIDIAP, 2010-2015.
    Herrera Comoglio R; Vidal Guitart X
    Prim Care Diabetes; 2021 Apr; 15(2):323-331. PubMed ID: 33248925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Can diabetes and its related hypoglycemic drug treatment be considered risk factors for health outcomes in COVID-19 patients? The results of a study in the population residing in Sicily Region (Southern Italy)].
    Cernigliaro A; Allotta AV; Scondotto S
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):315-322. PubMed ID: 33412824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin in type 2 diabetes: a useful alternative despite limited assessment based on surrogate endpoints.
    Prescrire Int; 2005 Oct; 14(79):187-93. PubMed ID: 16285076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary heart disease outcomes in patients receiving antidiabetic agents.
    McAfee AT; Koro C; Landon J; Ziyadeh N; Walker AM
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):711-25. PubMed ID: 17551989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of oral antidiabetic agents and risk of community-acquired pneumonia: a nested case-control study.
    Gorricho J; Garjón J; Alonso A; Celaya MC; Saiz LC; Erviti J; López A
    Br J Clin Pharmacol; 2017 Sep; 83(9):2034-2044. PubMed ID: 28294379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
    Ou HT; Chang KC; Li CY; Wu JS
    Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of metformin and insulin versus insulin alone for type 2 diabetes: systematic review of randomised clinical trials with meta-analyses and trial sequential analyses.
    Hemmingsen B; Christensen LL; Wetterslev J; Vaag A; Gluud C; Lund SS; Almdal T
    BMJ; 2012 Apr; 344():e1771. PubMed ID: 22517929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes treatment patterns and goal achievement in primary diabetes care (DiaRegis) - study protocol and patient characteristics at baseline.
    Bramlage P; Binz C; Gitt AK; Krekler M; Plate T; Deeg E; Tschöpe D
    Cardiovasc Diabetol; 2010 Sep; 9():53. PubMed ID: 20843379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.